Development of a bioartificial liver therapy in acute liver failure

Project Details


Refinement and application of a bioartificial liver support (BAL) system for patients with acute liver failure in collaboration between experts of both the College of Medicine and Veterinary Medicine (The Roslin Institute and Vet School, Clinical Toxicology, ITU and liver cell biologists) and with the University of Amsterdam, and 3 biopharmaceutical companies [Biopredic, (France), PharmaCell (Maastricht), HepArt(Amsterdam)]
Effective start/end date1/06/1231/05/15